Global Markets for Allergy Diagnostics and Treatments

Report Highlights

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Report Includes

• An overview of the global markets for allergy diagnostics and treatments.
• Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
• Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
• Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
• Profiles of major players in the allergy diagnostics and treatments industry.

Report Scope

This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:

• A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
• An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
• Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
• A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.

Analyst Credentials

Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to producing business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:

• Various medical device markets.
• High-growth and niche markets in healthcare and life sciences.
• Home healthcare market.
• Medical tourism.